Table 4.
Variables | Overall | Non-COVID era LDP | COVID era LDP | p value |
---|---|---|---|---|
Patients | 501 | 330 (65.87%) | 171 (34.13%) | |
Age (years) | 64.88 ± 14.30 | 64.73 ± 15.64 | 64.88 ± 14.30 | .91 |
Women | 281 (51.00%) | 190 (52.34%) | 91 (48.40%) | .38 |
Number of procedures | 551 | 363 (65.88%) | 188 (34.12%) | < .001 |
Ward of provenance (per procedure) | .048 | |||
Emergency department | 74 (13.43%) | 55 (15.15%) | 19 (10.11%) | |
General ward | 443 (80.40%) | 284 (78.24%) | 159 (84.57%) | |
Outpatients | 28 (5.08%) | 22 (6.06%) | 6 (3.19%) | |
Intensive care units | 6 (1.09%) | 2 (0.55%) | 4 (2.13%) | |
Procedural guidance | .49 | |||
Fluoroscopy | 256 (46.46%) | 167 (46.01%) | 89 (47.34%) | |
US | 99 (17.97%) | 71 (19.56%) | 28 (14.89%) | |
CT | 40 (7.26%) | 27 (7.44%) | 13 (6.91%) | |
US + CT | 3 (0.54%) | 1 (0.28%) | 2 (1.06%) | |
US + fluoroscopy | 153 (27.77%) | 97 (26.72%) | 56 (29.79%) | |
Bedside procedures | 4 (.73%) | 0 | 4 (2.13%) | .01 |
Type of procedure | .706 | |||
Diagnostic | 95 (17.24%) | 61 (16.80%) | 34 (18.09% | |
Therapeutic | 456 (82.76%) | 302 (83.20%) | 154 (81.91%) | |
Body part | .54 | |||
Head | 46 (8.35%) | 31 (8.54%) | 15 (7.98%) | |
Thorax | 45 (8.17%) | 31 (8.54%) | 14 (7.45%) | |
Abdomen | 387 (70.24%) | 248 (68.32%) | 139 (73.94%) | |
Bone | 13 (2.36%) | 8 (2.20%) | 5 (2.66%) | |
Others | 60 (10.89%) | 45 (12.40%) | 15 (7.98%) | |
Emergency procedures | .39 | |||
Elective | 350 (63.52%) | 226 (62.26%) | 124 (65.96%) | |
Emergency | 201 (36.48%) | 137 (37.74%) | 64 (34.04%) | |
Delay time-dependent procedures (min) | 86.5(40–180) | 50 (40–180) | 100(55–180) | |
Oncologic classes | .003 | |||
Procedures in non-oncologic patients | 210 (38.11%) | 157 (43.25%) | 53 (28.19%) | |
Procedures in oncologic patients | 230 (41.74%) | 138 (38.02%) | 92 (48.94%) | |
Oncologic treatments | 111 (20.15%) | 68 (18.73%) | 43 (22.87%) |
CT computed tomography, LDP lockdown period, min minutes, US ultrasound